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S194 Oral Presentationsfrom the National Database of Nursing Quality Indicators
(NDNQI) survey completed by patients upon discharge revealed
a gap in patient satisfaction with nursing assessment of patient
distress. In response to this data a literature search was per-
formed by members of a nursing-based Patient Satisfaction Com-
mittee (PSC) to determine what interventions would be
appropriate for assessing distress in the transplant inpatient set-
ting.
Aim/ObjectivesTo both monitor patient distress and increase com-
munication between the patient and nursing staff about areas of dis-
tress on a weekly basis.
Intervention Based on the literature review, the National Compre-
hensive Cancer Network’s Patient Distress Thermometer was im-
plemented during a four week pilot period on a 52-bed Stem Cell
Transplant and Cellular Therapy Unit. Members of the PSC in-ser-
viced staff on use of the distress thermometer, which was distributed
to patients on admission and then weekly every Wednesday. Upon
completion of the distress thermometer, nurses were asked to review
patient’s responses and refer accordingly if a need was identified, and
document this assessment and intervention in the daily nursing
notes.
Results/Evaluation Thus far, new referrals have been made dur-
ing for patients that may not have otherwise have been identified
without use of the distress thermometer. Nursing feedback on the
ease of use and efficacy of the tool was evaluated via an on-line
survey, which reported increased referrals with the use of the
tool. Further analysis of both nursing and feedback may indicate,
in accordance with the literature, the efficacy of the Distress
Thermometer in identifying and addressing distress in the
SCTCT population.102
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0 0RIT is routinely performed in an outpatient infusion center at
Children’s Memorial Hospital (CMH), Chicago, IL. We reviewed
infection patterns in children with PID who received RIT. Since
2000, 25 patients with the following diagnoses underwent RIT at
CMH: SCID (13), hyper-IgM syndrome (3), IPEX (2), WAS (2),
XLPD (2), reticular dysgenesis (1), Chediak-Higashi Syndrome
(1), and MHC class II deficiency (1). Sixty-four percent (16/25) of
patients received RIT on an outpatient basis. The remaining 9 pa-
tients were hospitalized for RIT due to pre-existing infection, com-
plication or parental preference. Conditioning consisted of
Fludarabine 30 mg/m2/day  6 days, Busulfan (IV) targeted to
AUC 4000-5000 microMol*min/day  2 days, and Thymoglobulin
2 mg/kg/day 4 days. Acyclovir, fluconazole, and pentamidine were
used for infection prophylaxis. Intravenous immunoglobulin (IVIG)
was administered every 3 weeks through day +100. Weekly CMV
and adenovirus PCR were done for all patients. Patients with fever
or signs of infection were admitted. Nurses performed caregiver ed-
ucation pre-RIT and at each outpatient visit on the following topics:
central line care, home medication administration, fever/neutrope-
nia guidelines, when to call the medical team, isolation measures,
and dietary restriction. Education was reinforced until understand-
ing was verbalized by caregiver. Infections documented within 180
days for all patients who underwent RIT include (table 1): bacter-
emia (29 episodes/14 patients), viremia (12 episodes/7 patients), fun-
gal infection (1). Eighty-nine percent and 33% of hospitalized
patients experienced bacteremia and viremia, respectively, as com-
pared to 38% and 25% of those treated as outpatients. EBV and
CMV transmission via breast milk were noted in 2 patients. Rapid
blood count recovery with satisfactory donor engraftment and early
immune reconstitution was noted in 22/25 patients (88%). Of these
22 patients, normal IgG levels were achieved by day +180 and IVIG
supplementation was discontinued. These patients had adequate
CD4 + T cells and were eligible for re-immunization between 270-
365 days. The 2-year OS was 93% for 16 patients who underwent
outpatient RIT compared to 78% for 9 patients who were hospital-
ized for RIT (P5 .09). The relatively low incidence of infections,
early immune reconstitution and lower mortality rate suggest that
outpatient RIT with nursing support, education and infection mon-
itoring is safe and effective for children with PID.Urine
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